| Management target | Revenue 15.0% FY27 |
|---|
| Revenue growth | 13% YoY growth; driven by pricing/mix, volumes down 5%. |
|---|---|
| Margins | EBITDA margin expanded 70 bps YoY to 15.6%. |
| Demand visibility | Strong recovery in NAFTA/LATAM; Europe de-stocking is temporary. |
| Management confidence | Balanced; optimistic on recovery in Europe, defensive on capex overshoot. |
Growth
Revenue grew 13% YoY to ₹1,052 Cr, driven by pricing and favorable product mix (+18.3%) offsetting 5.1% volume decline.
Outlook
Management maintains FY27 revenue growth guidance of 10-15% and EBITDA margins between 18-20%.
Risks
European market weakness persists due to extreme weather; unpredictable US registration costs led to a significant capex overshoot.
Last quarter's promises, checked
Delivered
- Guided prices to keep improving (no figure) → Q2 price/mix +18.3% vs Q1 mix -2.1% (= BEAT)
Partly delivered
- Guided FY27 revenue +10-15% → Q2 +13% (= PARTIAL, on track, full year unproven)
- Guided FY27 EBITDA margin 18-20% → Q2 15.6% (= PARTIAL, below range, annual unproven)
Missed
- Guided FY27 volume +5-10% → Q2 volume -5.1% (= MISS)
- Guided Europe recovery, next 3 qtrs better than Q1's -1.6% → Q2 -5.1%, Europe weakness persists (= MISS)
- Guided FY27 capex ~500 Cr (480-550 range), data costs 'not to repeat' → FY27 capex raised to 550-600 Cr, arbitration costs recurred (= MISS)
Earnings Call Transcript filed with NSE, NSE: SHARDACROP. Summary written with AI assistance from the document.
Sharda Cropchem Ltd: key numbers
- Share price
- ₹684.80
- Market cap
- ₹6,178 Cr
- Revenue (annual)
- ₹5,268 Cr
- Net profit (annual)
- ₹680.9 Cr
- P/E (TTM)
- 9.6×Sector 33.6×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 3.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharda Cropchem Ltd
All →Sharda Cropchem Results Update
Sharda Cropchem's Q2 FY27 revenue rose 13% to ₹1,052 crore; EBITDA grew 18% to ₹164 crore. H1 PAT declined 17% to ₹180 crore on lower forex gains.
Sharda Cropchem Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 1,052 Cr (+13%), EBITDA Rs 164 Cr (+18%), margin 15.6%, PAT Rs 92 Cr (+23%). H1 PAT down 17%.
Sharda Cropchem Q2 FY27 Results: Net Profit ₹91.7 Cr, Up 23.3% YoY
Sharda Cropchem Ltd reported revenue from operations of ₹1,052 Cr (+13.2% YoY) and net profit of ₹91.7 Cr (+23.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹91.7 Cr · +23.3% YoY
Sharda Cropchem Board Meeting Date
Sharada Cropchem scheduled a board meeting for 30 Oct 2026 to consider its H1 FY27 unaudited financial results. No financial figures or decisions are reported in this advance intimation.
Sharda Cropchem Other Announcement
Sharda Cropchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Sharda Cropchem Annual General Meeting
Sharda Cropchem Ltd held its 23rd AGM on August 14, 2026. Shareholders adopted financial statements and approved a final dividend of Rs. 9.00 per share.